Vensana Capital
Vensana Capital is a venture capital and growth equity investment firm dedicated to partnering with entrepreneurs who seek to transform healthcare with breakthrough innovations in medical technology. They actively invest in development and commercial stage companies across the medtech sector. Vensana values partnering with experienced management teams to amplify their success.
📥 Buy Full VC Dataset
Offices: Minneapolis (United States)
Investment Stages: Seed, Series A, Series B, Series C
Markets: Medical devices, diagnostics, drug delivery, digital health
Founded Year: 2018
Investor Type: Venture Capital
Portfolio Companies: Apella, Cartiva, ChromaCode, Cleerly, Curate BioSciences, CV Ingenuity, Epix Therapeutics, Evident Vascular, Intact Vascular, Personal Genome Diagnostics, PhaseBio Pharmaceuticals, Relievant Medsystems, Senseonics, Topera, Ulthera, Vertiflex, Vesper Medical, VytronUS, Artelon, Biotie Therapies, Cameron Health, CardiAQ, Inari Medical, Lutonix, NeuWave Medical, Sequent Medical, Veran Medical, Alleviant Medical, CVRx, Elucent Medical, iVEAcare, Moxe, Okami Medical, SpyGlass Pharma
Website: https://www.vensanacap.com
Team Page: https://www.vensanacap.com/our-team/
LinkedIn: https://www.linkedin.com/company/vensana-capital
Twitter: https://twitter.com/vensanacapital
Crunchbase: https://www.crunchbase.com/organization/vensana-capital
Pitchbook: https://pitchbook.com/profiles/investor/267678-91
Comments
No comments yet. Be the first to comment!